Skip to Content Facebook Feature Image

FutureGrail Sets New Sales Record for George Daniels Timepiece at May Auction

Business

FutureGrail Sets New Sales Record for George Daniels Timepiece at May Auction
Business

Business

FutureGrail Sets New Sales Record for George Daniels Timepiece at May Auction

2026-05-15 01:27 Last Updated At:01:45

Fierce competition for Patek Philippe, Rolex and Vacheron Constantin examples, with bids outperforming estimates across the board.

ABU DHABI, UAE, GENEVA and SINGAPORE, May 15, 2026 /PRNewswire/ -- FutureGrail has set new milestones for vintage watch valuations, with collectors from over 40 countries bidding on its May Auction. Results of the white-glove sale soared, including a new record performance for a Rolex Datejust modified by legendary watchmaker George Daniels. The exceptional timepiece scorched past estimates (between $100,000 to $200,000), with the hammer falling at $520,000.

Not a single lot was 'passed', reflecting a buoyant international market for rare and fine timepieces.

FutureGrail CEO, Ali Nael, said: "Strong demand from collectors and institutions has driven increased competition for exceptional timepieces across the spring auctions. This was reflected in our May sale, where collectors from around the world appreciated the rarity and condition of the selected timepieces. As expected, there was real excitement around these unique and historically important watches."

One of the most visually stunning watches to break new boundaries was a Patek Philippe in 18-carat yellow gold with diamonds and rubies. The Reference 4700 / 160J rocketed past top-end estimates, hammering at $400,000. There was also strong demand for Patek Philippe watches with rare 'lugs', including a Reference 1579J 'Spider Lugs' and a Reference 2549/1 J 'Turtle Lugs', and a Rolex Reference 2057 single-button chronograph.

While the popularity of extraordinary wristwatches is set to continue, Nael also believes vintage pocket watches are returning to fashion, with every pocket watch lot across the May auction meeting or exceeding estimates.

"Whether it's popular TV shows like Peaky Blinders or the latest eye-catching collaboration between Audemars Piguet and Swatch, there is a cultural renaissance around pocket watches. Collectors are realising the true beauty and heritage of these classic timepieces," added Nael.

FutureGrail is a leading auction house with global reach via its online auction platform and public museum. It continues to grow from its Singapore origins, with expansion across Switzerland and United Arab Emirates throughout 2026.

Collectors interested in consigning at one of FutureGrail's upcoming auctions can visit futuregrail.com/sell.

Media contact:
Jonathan Ivan-Duke, +971582857333, jon@dukemir.com
Jay Kau, +6017-9088 978, jay@futuregrail.com

Photo - https://mma.prnasia.com/media2/2980342/Rolex_Datejust_George_Daniels.jpg?p=medium600
Photo - https://mma.prnasia.com/media2/2980341/Patek_Philippe_Ref_4700_160J.jpg?p=medium600

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

FutureGrail Sets New Sales Record for George Daniels Timepiece at May Auction

FutureGrail Sets New Sales Record for George Daniels Timepiece at May Auction

FutureGrail Sets New Sales Record for George Daniels Timepiece at May Auction

FutureGrail Sets New Sales Record for George Daniels Timepiece at May Auction

NeuroEndocrine Cancer Australia (NECA) has launched a fully updated digital platform designed to improve how the 31,000 Australians affected by neuroendocrine cancer (NETs) access support, information, and specialist care.

SYDNEY, May 15, 2026 /PRNewswire/ -- The new website introduces a personalised patient hub experience aimed at helping people navigate every stage of the NET journey, from diagnosis through to treatment, remission, and ongoing support.

Neuroendocrine cancers are a complex and often misunderstood group of cancers that can develop anywhere in the body. Once considered rare, they now affect 18 in every 100,000 Australians (AIHW). Because symptoms are frequently vague or mistaken for other conditions, the common experience is one of delayed diagnosis and fragmented care.

The new platform was created to address these challenges by making trusted, specialist-led information easier to access and more tailored to the needs of patients, carers, and healthcare professionals.

The redesigned website includes:

  • A personalised patient hub to help users navigate relevant support and resources
  • Expanded education about NET symptoms, diagnosis, treatment, and side effects
  • Improved access to NET specialist services across Australia
  • Seamless connection to the NECA NET Nurse service and support programs
  • Enhanced patient stories and lived experience content
  • Mobile-friendly design and simplified navigation for improved accessibility

NeuroEndocrine Cancer Australia CEO Meredith Cummins said the new website represents a significant step forward in supporting Australians impacted by neuroendocrine cancer.

"People diagnosed with neuroendocrine cancer often feel isolated, overwhelmed, and unsure where to turn. This new platform has been designed to connect patients and families with the information, support, and specialist services they need."

The launch reflects growing demand for reliable digital health resources and recognises the increasing number of Australians being diagnosed with neuroendocrine cancers each year.

NECA says the patient hub will continue to evolve over time, with future enhancements based on ongoing user behaviour research, changes in best practice web design, and the evolution of digital content.

The new website is now live at: https://neuroendocrine.org.au/

Media Contact:
Ciara Connolly
Media & External Affairs
ciara@neuroendocrine.org.au

About NeuroEndocrine Cancer Australia
NeuroEndocrine Cancer Australia is the only Australian not-for-profit charity dedicated to supporting people affected by neuroendocrine cancers. The organisation provides specialist nurse support, education, advocacy, and funding for research to improve awareness, earlier diagnosis, and patient outcomes across Australia.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

NeuroEndocrine Cancer Australia unveils new website and digital lifeline

NeuroEndocrine Cancer Australia unveils new website and digital lifeline

Recommended Articles